Advanced NGS Oncology Testing

Cancer Genomics Testing Understanding Your Tumor at the Molecular Level

Premium 3D Cancer Genomics DNA Helix

Coverage

96% at 20x

Sample Type

Buccal / Saliva

Cancer is complex—but treatment should be smarter.

Advanced genomic sequencing helps identify the specific genetic mutations driving tumor growth, enabling more personalized treatment strategies, targeted therapies, and improved clinical outcomes.

7–10 Day Turnaround
38-Gene Panels
ACMG Standardized
Clinical Rationale

Why Cancer Genomics Testing Matters

Precision Treatment

Identify targeted therapies based on tumor mutations.

Molecular Understanding

Understand the genetic drivers behind tumor behavior.

Family Risk Detection

Identify hereditary cancer risks for family members.

Better Outcomes

Personalized treatment may reduce side effects and improve results.

Process Workflow

How Cancer Genomics Testing Works

01

Sample Collection

Buccal swab or saliva sample collected.

02

DNA Sequencing

Advanced NGS sequencing analyzes genetic mutations.

03

Mutation Analysis

Data compared against known cancer-related databases.

04

Clinical Insights

Providers receive precision-based treatment planning reports.

05

Personalized Care

Targeted therapy decisions based on molecular findings.

Diagnostic Scope

Cancer Types We Screen For

We leverage next-generation sequencing to evaluate high-risk mutations associated with multiple complex hereditary cancer pathways.

Breast Cancer

Target Panel

Ovarian Cancer

Target Panel

Prostate Cancer

Target Panel

Lung Cancer

Target Panel

Pancreatic Cancer

Target Panel

Colorectal Cancer

Target Panel

Stomach Cancer

Target Panel

Bladder Cancer

Target Panel

Melanoma

Target Panel

Lynch Syndrome

Target Panel
Hereditary Cancer Genomics

Hereditary Cancer Gene Panel

38 clinically relevant genes analyzed through advanced genomic sequencing to evaluate cancer predisposition.

Primary High-Risk Biomarkers

Core Target Genes

Our panel checks these essential genes known to be primary drivers of hereditary breast, ovarian, colorectal, and prostate cancer pathways.

BRCA1
BRCA2
TP53
ATM
APC
PALB2
CHEK2
PMS2

View Full 38-Gene Panel

Deeply index your search or review the full set of genes processed in this panel according to ACMG compliance.

Technical Sheet

Test Specifications

Sample Type

Buccal Swab / Saliva

Reporting

Pathogenic & Likely Pathogenic Variants

Turnaround Time

7–10 Business Days

Coverage

96% at 20x

Advanced Flexibility

Customizable Gene List

Provide diagnostic targeted panels aligned directly to your patient's family history or diagnostic path. Our team supports custom EMR-portal integrations, allowing specific sub-requisition panels.

Clinical Advantage

Why Providers Choose Cancer Genomics

Improved Diagnosis Accuracy

More precise clinical decisions.

Personalized Treatment

Target therapies aligned to mutation profile.

Family Risk Assessment

Identify inherited cancer predispositions.

Faster Decision Making

Rapid insights for time-sensitive care.

Reassurance Pathway

If Genetic Testing Finds
Elevated Risk

We focus on reducing anxiety. A positive variant finding is not a diagnosis of cancer; it is a powerful roadmap to build a highly optimized preventative pathway.

Step 01

Confirm Findings

Validate identified variants through rigorous clinical review.

Step 02

Physician Consultation

Collaborative review of clinical pathways with your provider.

Step 03

Personalized Care Planning

Tailor medical therapies and precision surveillance strategies.

Step 04

Family Risk Evaluation

Initiate directed cascade screening for first-degree relatives.

Step 05

Preventive Care Strategy

Establish early cancer surveillance and risk-reducing paths.

Educational Guide

Understanding Genetic Testing

What is Genetic Testing?

Genetic testing analyzes your DNA to identify specific hereditary variations (mutations) that significantly increase your susceptibility to developing particular cancer types. It determines inheritance pathways.

Why Is It Important?

Understanding genetic mutations early allows you and your healthcare provider to design tailored clinical screening protocols, introduce lifestyle risk reductions, or consider preventive medical paths.

Testing Outcomes

Results can be Positive (variant found), Negative (no high-risk variant identified in tested genes), or Uncertain (Variant of Uncertain Significance - meaning a change is detected but its clinical impact is undefined).

Personalized Medicine

Precision medicine utilizes your genomic data to customize clinical surveillance. It targets specific risk markers directly and removes ineffective one-size-fits-all medical approaches.

Insurance Information

Vediagnostics simplifies laboratory billing. We work directly with insurance providers to secure maximum coverage options for patients.

  • Verify commercial policy coverage
  • Identify physician clinical recommendation
  • Process secure laboratory prior authorizations
Have questions about billing? Contact our dedicated billing support desk.

Frequently Asked Questions

Precision Cancer
Insights Start Here

Early molecular understanding can lead to better treatment decisions, improved outcomes, and personalized care.